No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
No Data
No Data
No Data
No Data
Oramed Pharmaceuticals Welcomes New Audit Committee Chair
TipRanksMar 18 17:33 ET
Oramed Pharmaceuticals Updates Stock Sale Strategies and Partners
TipRanksMar 18 17:23 ET
Oramed Pharmaceuticals Full Year 2023 Earnings: Beats Expectations
Yahoo FinanceMar 9 09:32 ET
Oramed Plans New US Trial for Oral Insulin After Setback, Partners With HTIT to Commercialize Products
InvestingFeb 20 08:56 ET
Oramed Pharmaceuticals CEO Updates Shareholders on Strategy
TipRanksFeb 20 08:52 ET
MQ, ORMP and EXAI Are Among Pre Market Gainers
Seeking AlphaFeb 12 08:34 ET
No Data
No Data